Siomycin A Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells by Suppressing the Expression of FoxM1

• Published in: Natural product communications 2015-09, Vol.10 (9), p.1603-1606
• Main Authors: Guo, Xuedan, Liu, Aiping, Hua, Hongxia, Lu, Huifen, Zhang, Dandan, Lin, Yina, Sun, Qing, Zhu, Xue, Yan, Guoxin, Zhao, Fan
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - metabolism; Antineoplastic Agents - pharmacology; Antineoplastic Agents, Phytogenic - pharmacology; Apoptosis - drug effects; Cell Line, Tumor; Forkhead Box Protein M1; Forkhead Transcription Factors - genetics; Forkhead Transcription Factors - metabolism; Gene Expression Regulation, Neoplastic - drug effects; Humans; Lung Neoplasms - metabolism; Peptides - pharmacology
• ISSN: 1934-578X; 1555-9475
• DOI: 10.1177/1934578X1501000929

Forkhead box M1 (FoxM1), a transcription factor of the Forkhead family, is demonstrated to be critical for proliferation, apoptosis, migration and invasion of lung cancer. In this study, we extensively investigated the anticancer effect of siomycin A, which was identified as an inhibitor of FoxM1 transcriptional activity, on human lung adenocarcinoma A549 cells. Our study indicated that treatment with siomycin A resulted in the suppression of FoxM1 expression, which consequently contributed to its effect of cell growth inhibition and cell apoptosis induction in A549 cells. Then the molecular mechanism of siomycin A's apoptotic action on A549 cells was further investigated. The results revealed that siomycin A induced apoptosis by influencing the downstream events of FoxM1, including inhibiting the expression of Bcl-2 and Mcl-1, as well as leading to caspase-3 cleavage. Taken together, our findings may be useful for understanding the mechanism of action of siomycin A on lung cancer cells and provide new insights into the possible application of such a compound in lung cancer therapy in the future.